1. Medtech Insight
  2. >>Policy & Regulation

Boston Scientific’s Vici Stent Systems Subject Of Class I Recall

 
• By Shawn M. Schmitt

The company pulled the products from shelves because there’s a chance the stents can migrate, or move, from where they’re placed. This is Boston Scientific’s fourth high-risk class I recall this year.

Boston Scientific sign.

A recall of Boston Scientific Corp.’s Vici Stent Systems has been designated as high-risk class I by the US Food and Drug Administration.

The Vici Venous Stent System and Vici RDS Venous Stent System were yanked from shelves by the company last month...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Recalls

More from Policy & Regulation